Ludwig R. Frontier Ramos MD MSc MBA DHSc Scientific Marketing and Medical Manager for Macopharma, Atlanta, GA. Associate Researcher, Bioethics Faculty, Universidad Anáhuac México Globalization not only brought the world the advantage of universal access to knowledge but also presents...
The International Society for Cell & Gene Therapy (ISCT) celebrates the recent announcement of the U.S. Food and Drug Administration's (FDA) accelerated approval of Tecelra (afamitresgene autoleucel) for the treatment of adults with unresectable or metastatic synovial sarcoma who have...
The Rise of Asia Pacific: Learning From the Region’s Leaders and Innovators Organized by: ISCT Asia Regional Executive Committee Summary of Key Points from ISCT 2024 Vancouver Roundtable session on May 31, 8 am Moderator: Steve Oh, PhD - Independent Cell Therapy Leader, Singapore ...
Shyam Bhakta, MD, MBA National Center for Regenerative Medicine Case Western Reserve University Cleveland, Ohio, USA Human immunodeficiency virus (HIV) remains a significant global challenge and demands continuous progress in therapeutic approaches (1). Since the start of the epidemic, 85...
From the ISCT Exosomes Committee The ISCT Annual Meeting held this year in Vancouver featured a significant event titled "MSC-EVs: Paving the Road to Regulatory Approval," focusing on the potential of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) in clinical...
VANCOUVER, British Columbia, July 09, 2024 – The International Society for Cell & Gene Therapy (ISCT) commends the recent verdict in a landmark class action lawsuit against the Lung Institute, a provider of unproven cell-based therapies for patients with lung diseases. The case took place...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Dear ISCT membership as we come out of our annual meeting in Vancouver I take over as President and start my regular contributions to Telegraph. I aim to address topics that reflect the status of the field or relate to significant...
by the JSRM-ISCT iPSC Joint Committee JSRM-ISCT iPSC Joint Committee was established in December 2021, aiming to support the dissemination of iPSC-derived cell products as an emerging therapeutic platform in the field of cell therapy, alongside CAR-T and MSC therapies. The committee is co...
by The ISCT Exosomes Committee The ISCT Annual Meeting held this year in Vancouver featured a significant event titled "MSC-EVs: Paving the Road to Regulatory Approval," focusing on the potential of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) in clinical applications....
Nisa Renault, PhD Research & Development Associate Director FUJIFILM Cellular Dynamics Madison, Wisconsin, USA The Telegraft Editorial Board is excited to present another live Member Spotlight feature for the July issue. Telegraft editor Dr. Ashley Krull, Ph.D., sat down at the 2024...